Table V.
Correlation analyses between the genotypes and alleles of CT60 and clinical features of GD.
| Family history, n (%) | Ophthalmopathy, n (%) | Relapse history, n (%) | |||||
|---|---|---|---|---|---|---|---|
| Characteristics | (+) | (−) | (+) | (−) | (+) | (−) | |
| Genotype | |||||||
| GG | 59 (69.4) | 143 (70.4) | 14 (70.0) | 184 (68.6) | 21 (75.0) | 177 (68.1) | |
| AG | 25 (29.4) | 54 (26.6) | 5 (25.0) | 75 (28.0) | 6 (21.4) | 74 (28.4) | |
| AA | 1 (1.2) | 6 (3.0) | 1 (5.0) | 9 (3.4) | 1 (3.6) | 9 (3.5) | |
| χ2 test | 0.962 | 0.209 | 0.627 | ||||
| P-value | 0.618 | 0.901 | 0.731 | ||||
| Allele | |||||||
| G | 143 (84.1) | 340 (83.7) | 33 (82.5) | 443 (82.6) | 48 (85.7) | 428 (82.3) | |
| A | 27 (15.9) | 66 (16.3) | 7 (17.5) | 93 (17.4) | 8 (14.3) | 92 (17.7) | |
| χ2 test | 0.012 | 0.037 | 0.206 | ||||
| P-value | 0.911 | 0.847 | 0.650 | ||||
GD, Graves' disease.